Evidence-led vulnerability intelligence · 2026-09-16 01:48 IST

CVE-2026-83081

Vulnerability in the Oracle Banking Corporate Lending product of Oracle Financial Services Applications (component: Core). Supported versions that are affected are 14.5.0.0.0-14.9.0.0.0. Difficult to exploit vulnerability allows unauthenticated attacker with access to the physical communication segment attached to the hardware where the Oracle Banking Corporate Lending executes to compromise Oracle Banking Corporate Lending. While the vulnerability is in Oracle Banking Corporate Lending, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Banking Corporate Lending accessible data as well as unauthorized access to critical data or complete access to all Oracle Banking Corporate Lending accessible data. CVSS 3.1 Base Score 8.0 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:A/AC:H/PR:N/UI:N/S:C/C:H/I:H/A:N).

HIGH · 8.0Databases

Executive briefing

A structured intelligence assessment has not yet been generated. The source description is shown above. The background enrichment worker will retry this record.

Assessment: Potential exposure only — validate product, version, configuration and vendor applicability.

Evidence confidence: Not assessed Evidence-derived, not an exploitability verdict

Severity & attack characteristics

8.0 / 10 · CVSS

CVSS vector:
Not supplied

No CVSS vector is currently available in the source record.

Technical explanation & impact

Technical root-cause details are not available in the current source record.

Assess the impact using the published CVSS metrics and the affected vendor component.

Affected products and versions

NVD has not supplied machine-readable vulnerable CPE product/version entries for this CVE. This is an information gap, not proof that no products are affected. Check the vendor advisory references below.

Remediation & validation

  1. Identify exposure by comparing the affected product and version ranges with your asset inventory, SBOM and externally exposed services.
  2. Review the linked vendor security advisory or patch notes. Upgrade to a vendor-confirmed fixed release; do not infer a fixed version from the CVE description.
  3. Until patched, consider restricting network access or disabling the affected feature where operationally safe. These are temporary controls, not a substitute for a vendor fix.
  4. Validate the remediation with a version check and vulnerability rescan, then retain change evidence.

No fixed version is displayed unless it is explicitly established by a vendor advisory. Follow the vendor's release notes for exact product and branch applicability.

Vendor advisories, patches & exploit references

No external references are currently supplied in the CVE record.

Open NVD record ← Back to CVE Watch